Importance of animal models in schizophrenia research

References

• Preuss T M. Taking the measure of diversity: comparative alternatives to the model-animal paradigm in cortical neuroscience. Brain, Behaviour and Evolution 2000; 55: 287–299
   PubMed Web of Science ®Google Scholar
• National Health and Medical Research Council, Commonwealth Scientifc and Industrial Research Organization, Australian Agricultural Council. Australian code of practice for the care and use of animals for scientific purposes. Australian Government Publishing Service, Canberra 1990
   Google Scholar
• Geyer M A, Markou A. Animal models of psychiatric disorders. Psychopharmacology: the fourth generation of progress, F E Bloom, D J Kupfer. Raven, New York 1995; 787–798
   Google Scholar
• Ellenbroek B A, Cools A R. Animal models with construct validity for schizophrenia. Behavioural Pharmacology 1990; 1: 469–490
   PubMedGoogle Scholar
• Ellenbroek B A, Cools A R. Animal models for the negative symptoms of schizophrenia. Behavioural Pharmacology 2000; 11: 223–233
   PubMed Web of Science ®Google Scholar
• Creese I, Iversen S D. The pharmacological and anatomical substrates of the amphetamine response in the rat. Brain Research 1975; 83: 419–436
   PubMed Web of Science ®Google Scholar
• Kelly P H, Seviour P W, Iversen S D. Amphetamine and apomorphine responses in the rat following 6-OHDA lesions of the nucleus accumbens septi and corpus striatum. Brain Research 1975; 94: 507–522
   PubMed Web of Science ®Google Scholar
• Drevets W C, Gautier C, Price J C, et al. Amphetamine-induced dopamine release in human ventral striatum correlates with euphoria. Biological Psychiatry 2001; 49: 81–96
   PubMed Web of Science ®Google Scholar
• Martinez D, Slifstein M, Broft A, et al. Imaging human mesolimbic dopamine transmission with positron emission tomography. Part II: amphetamine-induced dopamine release in the functional subdivisions of the striatum. Journal of Cerebral Blood Flow and Metabolism 2003; 23: 285–300
   PubMed Web of Science ®Google Scholar
• Laruelle M, Abi-Dargham A, van Dyck C H, et al. Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects. Proceedings of the National Academy of Sciences of the United States of America. 1996, 9235–9240, 93
   Google Scholar
• Laruelle M, Abi-Dargham A, Gil R, Kegeles L, Innis R. Increased dopamine transmission in schizophrenia: relationship to illness phases. Biological Psychiatry 1999; 46: 56–72
   PubMed Web of Science ®Google Scholar
• Dean B. The cortical serotonin2A receptor and the pathology of schizophrenia: a likely accomplice. Journal of Neurochemistry 2003; 85: 1–13
   PubMed Web of Science ®Google Scholar
• Kusljic S, Copolov D L, Van den Buuse M. Differential role of serotonergic projections arising from the dorsal and median raphe nuclei in locomotor hyperactivity and prepulse inhibition. Neuropsychopharmacology 2003; 28: 2138–2147
   PubMed Web of Science ®Google Scholar
• Kusljic S, Brosda J, Norman T R, Van den Buuse M. Serotonergic lesions of the median raphe nucleus enhance the psychotomimetic action of phencyclidine, but not dizocilpine (MK-801) in rats. Brain Research 2005, (in press)
   PubMed Web of Science ®Google Scholar
• Harrison B J, Olver J S, Norman T R, Nathan P J. Effects of serotonin and catecholamine depletion on interleukin-6 activation and mood in human volunteers. Human Psychopharmacology 2002; 17: 293–297
   PubMed Web of Science ®Google Scholar
• Kusljic S, Van den Buuse M. Functional dissociation between serotonergic pathways in dorsal and ventral hippocampus in psychotomimetic drug-induced locomotor hyperactivity and prepulse inhibition in rats. European Journal of Neuroscience 2004; 20: 3424–3432
   PubMed Web of Science ®Google Scholar
• Van den Buuse M, Garner B, Koch M. Neurodevelopmental models of schizophrenia: effects on prepulse inhibition. Current Molecular Medicine 2003; 3: 459–471
   PubMed Web of Science ®Google Scholar
• Maynard T M, Sikich L, Lieberman J A, LaMantia A S. Neural development, cell–cell signaling, and the “two-hit” hypothesis of schizophrenia. Schizophrenia Bulletin 2001; 27: 457–476
   PubMed Web of Science ®Google Scholar
• Pantelis C, Yucel M, Wood S J, McGorry P D, Velakoulis D. Early and late neurodevelopmental disturbances in schizophrenia and their functional consequences. Autralian and New Zealand Journal of Psychiatry 2003; 37: 399–406
   PubMed Web of Science ®Google Scholar
• Geyer M A, Krebs-Thomson K, Braff D L, Swerdlow N R. Pharmacological studies of prepulse inhibition models of sensorimotor gating deficits in schizophrenia: a decade in review. Psychopharmacology 2001; 156: 117–154
   PubMed Web of Science ®Google Scholar
• Swerdlow N R, Geyer M A, Braff D. Neural circuit regulation of prepulse inhibition of startle in the rat: current knowledge and future challenges. Psychopharmacology 2001; 156: 194–215
   PubMed Web of Science ®Google Scholar
• Braff D L, Swerdlow N R, Geyer M A. Gating and habituation deficits in the schizophrenia disorders. Clinical Neuroscience 1995; 3: 131–139
   PubMedGoogle Scholar
• Geyer M A, McIlwain K L, Paylor R. Mouse genetic models for prepulse inhibition: an early review. Molecular Psychiatry 2002; 7: 1039–1053
   PubMed Web of Science ®Google Scholar
• Van den Buuse M. Deficient prepulse inhibition of acoustic startle in Hooded–Wistar rats compared with Sprague–Dawley rats. Clinical and Experimental Pharmacology and Physiology 2003; 30: 254–261
   PubMed Web of Science ®Google Scholar
• Van den Buuse M. Prepulse inhibition of acoustic startle in spontaneously hypertensive rats. Behavioural Brain Research 2004; 154: 331–337
   PubMed Web of Science ®Google Scholar
• Martin S, Lawrence A J, Van den Buuse M. Prepulse inhibition in Fawn–Hooded rats: increased sensitivity to 5-HT1A receptor stimulation. European Neuropsychopharmacology 2004; 14: 373–379
   PubMed Web of Science ®Google Scholar
• Wang J H, Short J L, Ledent C, Lawrence A J, van den Buuse M. Reduced startle habituation and prepulse inhibition in mice lacking the adenosine A2A receptor. Behavioural Brain Research 2003; 143: 201–207
   PubMed Web of Science ®Google Scholar
• Gogos A, Van den Buuse M. Castration reduces the effect of serotonin-1A receptor stimulation on prepulse inhibition in rats. Behavioral Neuroscience 2003; 117: 1407–1415
   PubMed Web of Science ®Google Scholar
• Gogos A, Van den Buuse M. Estrogen and progesterone prevent disruption of prepulse inhibition by the serotonin-1A receptor agonist 8-OH-DPAT. Journal of Pharmacology and Experimental Therapeutics 2004; 309: 267–274
   PubMed Web of Science ®Google Scholar
• Castle D, Sham P, Murray R. Differences in distribution of ages of onset in males and females with schizophrenia. Schizophrenia Research 1998; 33: 179–183
   PubMed Web of Science ®Google Scholar
• Kulkarni J, de Castella A, Smith D, Taffe J, Keks N, Copolov D. A clinical trial of the effects of estrogen in acutely psychotic women. Schizophrenia Research 1996; 20: 247–252
   PubMed Web of Science ®Google Scholar
• Kulkarni J, Riedel A, de Castella A R, et al. Estrogen – A potential treatment for schizophrenia. Schizophrenia Research 2001; 48: 137–144
   PubMed Web of Science ®Google Scholar
• Sams-Dodd F. Automation of the social interaction test by a video-tracking system: behavioural effects of repeated phencyclidine treatment. Journal of Neuroscience Methods 1995; 59: 157–167
   PubMed Web of Science ®Google Scholar
• Sams-Dodd F. Phencyclidine in the social interaction test: an animal model of schizophrenia with face and predictive validity. Reviews in Neuroscience 1999; 10: 59–90
   PubMed Web of Science ®Google Scholar
• Morris R GM, Garrud P, Rawlins J NP, O'Keefe J. Place navigation impaired in rats with hippocampal lesions. Nature 1982; 297: 681–683
   PubMed Web of Science ®Google Scholar
• Martin S, Jones M E, Simpson E R, Van den Buuse M. Impaired spatial working memory in aromatase-deficient (ArKO) mice. Neuroreport 2003; 14: 1979–1982
   PubMed Web of Science ®Google Scholar
• Schwabe K, Enkel T, Klein S, Schütte M, Koch M. Effects of neonatal lesions of the medial prefrontal cortex on adult rat behaviour. Behavioural Brain Research 2004; 153: 21–34
   PubMed Web of Science ®Google Scholar
• Harrison P J, Weinberger D R. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Molecular Psychiatry 2005; 10: 40–68
   PubMed Web of Science ®Google Scholar
• Bunney W E, Bunney B G, Vawter M P, et al. Microarray technology: a review of new strategies to discover candidate vulnerability genes in psychiatric disorders. American Journal of Psychiatry 2003; 160: 657–666
   PubMed Web of Science ®Google Scholar
• Swerdlow N R, Shoemaker J M, Platten A, Pitcher L, Goins J, Crain S. Heritable differences in the effects of amphetamine but not DOI on startle gating in albino and hooded outbred rat strains. Pharmacology, Biochemistry and Behavior 2003; 75: 191–197
   PubMed Web of Science ®Google Scholar
• Palmer A A, Breen L L, Flodman P, Conti L H, Spence M A, Printz M P. Identification of quantitative trait loci for prepulse inhibition in rats. Psychopharmacology (Berlin) 2003; 165: 270–279
   PubMed Web of Science ®Google Scholar
• Gainetdinov R R, Mohn A R, Caron M G. Genetic animal models: focus on schizophrenia. Trends in Neuroscience 2001; 24: 527–533
   PubMed Web of Science ®Google Scholar
• In vivo Pharmacology Training Group. The fall and rise of in vivo pharmacology. Trends in Pharmacological Sciences 2002; 23: 13–18
   PubMed Web of Science ®Google Scholar
• Crawley J N, Paylor R. A proposed test battery and constellations of specific behavioral paradigms to investigate the behavioral phenotypes of transgenic and knockout mice. Hormones and Behaviour 1997; 31: 197–211
   PubMed Web of Science ®Google Scholar
• Kulkarni J. Women and schizophrenia: a review. Australian and New Zealand Journal of Psychiatry 1997; 31: 46–56
   PubMed Web of Science ®Google Scholar
• Fisher C R, Graves K H, Parlow A F, Simpson E R. Characterization of mice deficient in aromatase (ArKO) because of targeted disruption of the cyp19 gene. Proceedings of the National Academy of Sciences of the United States of America. 1998, 6965–6970, 95
   Google Scholar
• Britt K L, Drummond A E, Cox V A, et al. An age-related ovarian phenotype in mice with targeted disruption of the Cyp 19 (aromatase) gene. Endocrinology 2000; 141: 2614–2623
   PubMed Web of Science ®Google Scholar
• Van den Buuse M, Simpson E R, Jones M E. Prepulse inhibition of acoustic startle in aromatase knock-out mice: effects of age and gender. Genes, Brain and Behavior 2003; 2: 93–102
   PubMed Web of Science ®Google Scholar
• Paylor R, Crawley J N. Inbred strain differences in prepulse inhibition of the mouse startle response. Psychopharmacology 1997; 132: 169–180
   PubMed Web of Science ®Google Scholar
• Crawley J N. Behavioral phenotyping of transgenic and knockout mice: experimental design and evaluation of general health, sensory functions, motor abilities, and specific behavioral tests. Brain Research 1999; 835: 18–26
   PubMed Web of Science ®Google Scholar
• Rehn A E, Van den Buuse M, Copolov D, Briscoe T, Lambert G, Rees S. An animal model of chronic placental insufficiency: relevance to neurodevelopmental disorders including schizophrenia. Neuroscience 2004; 129: 381–391
   PubMed Web of Science ®Google Scholar
• Van den Buuse M, Eikelis N. Estrogen increases prepulse inhibition of acoustic startle in rats. European Journal of Pharmacology 2001; 425: 33–41
   PubMed Web of Science ®Google Scholar